In vitro release profiles for INTAC® single entity, FDCs, and multi-modal preparations1-3

INTAC® can be tailored to a variety of release profiles from minutes up to 24 hours

 

References:
1. Bartholomäus J, Schwier S, Brett M, Stahlberg HJ, Galia E, Strothmann K. New abuse deterrent formulation (ADF) technology for immediate-release opioids. Drug Dev Deliv. 2013;13(8):76-81.
2. Wening K, Barnscheid L. Abuse deterrent formulations for fixed-dose combinations and products with multi-modal release properties for opioids and stimulants using INTAC® technology. Poster presented at: AAPS Annual Meeting 2015; Orlando, FL.
3.Wening K, Schwier S, Stahlberg HJ, Galia E. Application of hot-melt extrusion technology in immediate-release abuse-deterrent formulations. November 2017, Journal of opioid management 13(6):473-484

 

INTAC®